[HTML] sciencedirect.com

[HTML][HTML] Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis

R Altaf, I Gonzalez, K Rubino, EC Nemec II - Complementary therapies in …, 2021 - Elsevier
Objective Evaluate depression scores, response, and remission rates in patients with major
depression receiving adjunct therapy with folate (L-Methylfolate or folic acid) compared to …
被引用次数：27 相关文章

Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis

R Altaf, I Gonzalez, K Rubino… - Complementary …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective Evaluate depression scores, response, and remission rates in patients with major
depression receiving adjunct therapy with folate (L-Methylfolate or folic acid) compared to …

Folate as Adjunct Therapy to SSRI/SNRI for Major Depressive Disorder: Systematic Review & Meta-Analysis

R Altaf, I Gonzalez, K Rubino, EC Nemec - 2021 - digitalcommons.sacredheart.edu
Objective: Evaluate depression scores, response, and remission rates in patients with major
depression receiving adjunct therapy with folate (L-Methylfolate or folic acid) compared to …
[PDF] academia.edu

[PDF][PDF] Folate as Adjunct Therapy to SSRI/SNRI for Major Depressive Disorder: Systematic Review & Meta-Analysis

R Altaf, I Gonzalez, K Rubino… - … Therapies in Medicine, 2021 - academia.edu
Objective: Evaluate depression scores, response, and remission rates in patients with major
depression receiving adjunct therapy with folate (L-Methylfolate or folic acid) compared to …

Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis.

R Altaf, I Gonzalez, K Rubino… - … Therapies in Medicine, 2021 - europepmc.org
Objective Evaluate depression scores, response, and remission rates in patients with major
depression receiving adjunct therapy with folate (L-Methylfolate or folic acid) compared to …